XML 66 R5.htm IDEA: XBRL DOCUMENT v3.19.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total Shareholders' Equity Attributable to Bruker Corporation
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests in Consolidated Subsidiaries
Redeemable Noncontrolling Interest
Total
Balance at beginning of period at Dec. 31, 2017 $ 725.4 $ 1.7 $ (401.2) $ 155.9 $ 942.0 $ 27.0 $ 8.1   $ 733.5
Balance (in shares) at Dec. 31, 2017   155,865,977 16,009,099            
Increase (Decrease) in Stockholders' Equity                  
Restricted shares terminated (in shares)   (6,553) 6,553            
Stock options exercised 2.9     2.9         2.9
Stock options exercised (in shares)   180,890              
Restricted stock units vested (in shares)   42,762              
Stock based compensation 2.5     2.5         2.5
Shares issued for acquisition (0.1)   $ (0.1)           (0.1)
Shares issued for acquisition (in shares)   (2,123) 2,123            
Treasury stock acquired (in shares)   (1,055) 1,055            
Adoption impact from new revenue standard ASC 606 5.9       5.9   0.2   6.1
Cash dividends paid to common stockholders (6.3)       (6.3)       (6.3)
Consolidated net income (loss) 27.0       27.0   0.4   27.4
Other comprehensive income (loss) 24.2         24.2 0.1   24.3
Balance at end of period at Mar. 31, 2018 781.5 $ 1.7 $ (401.3) 161.3 968.6 51.2 8.8   790.3
Balance (in shares) at Mar. 31, 2018   156,079,898 16,018,830            
Balance at beginning of period at Dec. 31, 2017 725.4 $ 1.7 $ (401.2) 155.9 942.0 27.0 8.1   733.5
Balance (in shares) at Dec. 31, 2017   155,865,977 16,009,099            
Balance at end of period at Sep. 30, 2018 816.9 $ 1.7 $ (401.5) 173.3 1,030.7 12.7 8.3   825.2
Balance (in shares) at Sep. 30, 2018   156,512,202 16,024,880            
Balance at beginning of period at Mar. 31, 2018 781.5 $ 1.7 $ (401.3) 161.3 968.6 51.2 8.8   790.3
Balance (in shares) at Mar. 31, 2018   156,079,898 16,018,830            
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 4.2     4.2         4.2
Stock options exercised (in shares)   221,464              
Restricted stock units vested (in shares)   5,964              
Stock based compensation 2.4     2.4         2.4
Treasury stock acquired (0.1)   $ (0.1)           (0.1)
Treasury stock acquired (in shares)   (1,384) 1,384            
Cash dividends paid to common stockholders (6.2)       (6.2)       (6.2)
Consolidated net income (loss) 31.2       31.2   0.3   31.5
Other comprehensive income (loss) (36.4)         (36.4) (0.4)   (36.8)
Balance at end of period at Jun. 30, 2018 776.6 $ 1.7 $ (401.4) 167.9 993.6 14.8 8.7   785.3
Balance (in shares) at Jun. 30, 2018   156,305,942 16,020,214            
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 2.5     2.5         2.5
Stock options exercised (in shares)   127,003              
Restricted stock units vested (0.4)     (0.4)         (0.4)
Restricted stock units vested (in shares)   83,923              
Stock based compensation 3.3     3.3         3.3
Treasury stock acquired (0.1)   $ (0.1)           (0.1)
Treasury stock acquired (in shares)   (4,666) 4,666            
Distributions to noncontrolling interests             (0.9)   (0.9)
Cash dividends paid to common stockholders (6.3)       (6.3)       (6.3)
Consolidated net income (loss) 43.4       43.4   0.7   44.1
Other comprehensive income (loss) (2.1)         (2.1) (0.2)   (2.3)
Balance at end of period at Sep. 30, 2018 816.9 $ 1.7 $ (401.5) 173.3 1,030.7 12.7 8.3   825.2
Balance (in shares) at Sep. 30, 2018   156,512,202 16,024,880            
Balance at beginning of period at Dec. 31, 2018 896.6 $ 1.7 $ (401.5) 176.9 1,102.5 17.0 8.5 $ 22.6 905.1
Balance (in shares) at Dec. 31, 2018   156,609,340 16,024,880            
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 3.1     3.1         3.1
Stock options exercised (in shares)   167,177              
Restricted stock units vested (in shares)   35,072              
Stock based compensation 2.7     2.7         2.7
Shares issued for acquisition (in shares)   3,087 (3,087)            
Cash dividends paid to common stockholders (6.3)       (6.3)       (6.3)
Consolidated net income (loss) 30.8       30.8   0.1 (0.2) 30.9
Other comprehensive income (loss) (13.7)         (13.7) (0.2) (0.4) (13.9)
Balance at end of period at Mar. 31, 2019 913.2 $ 1.7 $ (401.5) 182.7 1,127.0 3.3 8.4 22.0 921.6
Balance (in shares) at Mar. 31, 2019   156,814,676 16,021,793            
Balance at beginning of period at Dec. 31, 2018 896.6 $ 1.7 $ (401.5) 176.9 1,102.5 17.0 8.5 22.6 905.1
Balance (in shares) at Dec. 31, 2018   156,609,340 16,024,880            
Balance at end of period at Sep. 30, 2019 845.2 $ 1.7 $ (543.8) 193.8 1,212.3 (18.8) 9.5 20.9 854.7
Balance (in shares) at Sep. 30, 2019   153,945,784 19,346,577            
Balance at beginning of period at Mar. 31, 2019 913.2 $ 1.7 $ (401.5) 182.7 1,127.0 3.3 8.4 22.0 921.6
Balance (in shares) at Mar. 31, 2019   156,814,676 16,021,793            
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 2.7     2.7         2.7
Stock options exercised (in shares)   145,606              
Restricted stock units vested (in shares)   2,344              
Stock based compensation 2.6     2.6         2.6
Shares repurchased (100.0)   $ (100.0)           (100.0)
Shares repurchased (in shares)   (2,300,635) 2,300,635            
Cash dividends paid to common stockholders (6.3)       (6.3)       (6.3)
Consolidated net income (loss) 36.5       36.5   0.8 (0.3) 37.3
Other comprehensive income (loss) 12.1         12.1 0.1 0.3 12.2
Balance at end of period at Jun. 30, 2019 860.8 $ 1.7 $ (501.5) 188.0 1,157.2 15.4 9.3 22.0 870.1
Balance (in shares) at Jun. 30, 2019   154,661,991 18,322,428            
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 3.1     3.1         3.1
Stock options exercised (in shares)   152,918              
Restricted stock units vested (0.8)     (0.8)         (0.8)
Restricted stock units vested (in shares)   155,024              
Stock based compensation 3.5     3.5         3.5
Shares repurchased (42.3)   $ (42.3)           (42.3)
Shares repurchased (in shares)   (1,022,469) 1,022,469            
Treasury stock acquired (in shares)   (1,680) 1,680            
Cash dividends paid to common stockholders (6.2)       (6.2)       (6.2)
Consolidated net income (loss) 61.3       61.3   0.4 (0.2) 61.7
Other comprehensive income (loss) (34.2)         (34.2) (0.2) (0.9) (34.4)
Balance at end of period at Sep. 30, 2019 $ 845.2 $ 1.7 $ (543.8) $ 193.8 $ 1,212.3 $ (18.8) $ 9.5 $ 20.9 $ 854.7
Balance (in shares) at Sep. 30, 2019   153,945,784 19,346,577